Peer Review History

Original SubmissionMarch 19, 2023
Decision Letter - Thiago P. Fernandes, Editor

PONE-D-23-07288Structural aging of human neurons is opposite of the changes in schizophreniaPLOS ONE

Dear Dr. Mizutani,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 23 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Thiago P. Fernandes, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have a patent relating to material pertinent to this article. Please provide an amended statement of Competing Interests to declare this patent (with details including name and number), along with any other relevant declarations relating to employment, consultancy, patents, products in development or modified products etc. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

This information should be included in your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The referee has followed the nanoCT papers of brain tissue from this group for some time. The data in the present manuscript represent a very large amount of additional work. The referee recommends that the present paper be accepted after so small improvements are made.

The referee is not a brain researcher and cannot comment, therefore, on the literature cited in the Introduction and Discussion. The x-ray imaging will absolutely solid, in the referee’s opinion.

The Results explain the data concisely but clearly. The details are given in the Supplementary Tables, and all of the samples appear in the main figures or the supplementary figures. Thus, reporting is thorough.

In the Discussion, the authors write (lines 335-339) “Although a methodology to manipulate neuron structure of a specific brain area is currently unavailable, neurite curvature can be used as a hallmark with which to exploit antipsychotics or other interventions that can moderate hallucinations.” This is clumsy, in the referee’s opinion, because the first clause says we cannot change neuron structure and the second part of the sentence sounds like neurite curvature is a hallmark with which to exploit antipsychotics…, which cannot be correct because this brain tissue is only available post mortem. The referee is not at all sure what is meant, and this portion of the Discussion must be clear.

The referee was unclear about the designations: “S7A, S7B, S7C…”. This needs to explicitly clarified. Designators S and N clearly refer to diseased and normal tissue. The 7 must be individual 7, one guesses. Does the last letter indicate different portions of tissue from the individual (here #7)?

Minor point: S2 Table lists pixel sizes. One presumes these are actually the reconstructed volume element (voxel) sizes. If so, this should be changed because pixels are 2D features.

Reviewer #2: Dear Authors,

Thanks for your work.

There are a few comments about this work.

1. The introduction does not contain a clear statement of the purpose of the study. The introduction contains an indication of the results that you are yet planning to present here.

2. The description of the norm group is insufficient. There is no indication of what diseases the subjects suffered. It is not excluded the influence of these diseases on the brain.

3. It is necessary to justify the choice of t-test for statistical analysis.

4. In the Discussion section, the wording is questionable: "Cognitive functions in schizophrenia do not worsen over time." The authors provide references to older publications.

5. You need to add a Conclusions section.

6. It is necessary to transfer the information from the Discussion section to the special section "Restrictions of the study".

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Stuart R. Stock

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

PONE-D-23-07288

Point-by-point responses to the reviewer comments

We would like to thank the editor and reviewers for their careful review of our manuscript and for their feedback. We believe this updated manuscript addresses the concerns. The Supporting Information section was moved to the end of the manuscript according to the journal guideline.

Reviewer #1: The referee has followed the nanoCT papers of brain tissue from this group for some time. The data in the present manuscript represent a very large amount of additional work. The referee recommends that the present paper be accepted after so small improvements are made.

The referee is not a brain researcher and cannot comment, therefore, on the literature cited in the Introduction and Discussion. The x-ray imaging will absolutely solid, in the referee’s opinion.

The Results explain the data concisely but clearly. The details are given in the Supplementary Tables, and all of the samples appear in the main figures or the supplementary figures. Thus, reporting is thorough.

We sincerely thank you for your appropriate and fair evaluation of this study.

In the Discussion, the authors write (lines 335-339) “Although a methodology to manipulate neuron structure of a specific brain area is currently unavailable, neurite curvature can be used as a hallmark with which to exploit antipsychotics or other interventions that can moderate hallucinations.” This is clumsy, in the referee’s opinion, because the first clause says we cannot change neuron structure and the second part of the sentence sounds like neurite curvature is a hallmark with which to exploit antipsychotics…, which cannot be correct because this brain tissue is only available post mortem. The referee is not at all sure what is meant, and this portion of the Discussion must be clear.

Thank you for the suggestion. Since the neurite curvature showed a significant correlation with the auditory hallucination score (Fig. 5), it can be used as a measure of hallucination even in animal disease models. The sentence was revised in order to clarify the discussion (p. 15, lines 345-347 in the file w/o track changes).

The referee was unclear about the designations: “S7A, S7B, S7C…”. This needs to explicitly clarified. Designators S and N clearly refer to diseased and normal tissue. The 7 must be individual 7, one guesses. Does the last letter indicate different portions of tissue from the individual (here #7)?

Thank you for the suggestion. Dataset S7A stands for dataset A of schizophrenia case S7. This is now explicitly stated in the revised manuscript (p. 6, line 145). Multiple datasets were taken from different portions of the tissue during the same beamtime, or from different tissue samples if the data collection was performed on different beamtimes. The cortical depth of each dataset is listed in S4 Tables A-H.

Minor point: S2 Table lists pixel sizes. One presumes these are actually the reconstructed volume element (voxel) sizes. If so, this should be changed because pixels are 2D features.

Thank you for the suggestion. The "Image size (pixel)" fields of S4 Tables are now revised as "Image size (voxel)". S3 Table (formerly S2) shows the conditions of the micro/nano-CT experiments; hence, the parameters represent features of 2D pixels.

Reviewer #2: Dear Authors,

Thanks for your work.

There are a few comments about this work.

1. The introduction does not contain a clear statement of the purpose of the study. The introduction contains an indication of the results that you are yet planning to present here.

Thank you for the suggestion. The sentence which contains an indication of the results was revised in order to state the purpose of this study (p. 3, lines 74-77 in the file w/o track changes).

2. The description of the norm group is insufficient. There is no indication of what diseases the subjects suffered. It is not excluded the influence of these diseases on the brain.

Thank you for the suggestion. Causes of death of all the cases are now listed in S2 Table. Cases with diseases known to be directly related to the brain area under analysis were not included in this study. Histological assessment of the cerebral tissues showed no hemorrhage, infarction, or neoplasm. This is stated in p. 5, lines 104-105. It is possible that the cause of death in each case may have influenced the results. This is now stated in the Limitations section (p. 15, lines 355-356). The table numbering was revised in order to cite S2 Table in the first subsection of the Methods.

3. It is necessary to justify the choice of t-test for statistical analysis.

Since the mean follows a normal distribution, the use of a t-test is justified for the statistical analysis of mean values. The related sentence was revised (p. 7, lines 161-162). Since Shapiro-Wilk normality tests of standard deviations of the neurite curvature showed no statistical significance (p = 0.30 for schizophrenia cases and p = 0.94 for controls), the use of a t-test was justified for the statistical analysis of their difference (p. 7, lines 163-166). The statistical analyses in this study were conducted under the direction of coauthor Yoshiro Yamamoto, whose expertise is statistics. All data needed for the statistical analyses are provided in S1-S4 Tables.

4. In the Discussion section, the wording is questionable: "Cognitive functions in schizophrenia do not worsen over time." The authors provide references to older publications.

Thank you for the suggestion. The related sentences were revised (p. 14, lines 317-320). The former references were replaced with the following papers:

46. Fett AJ, Reichenberg A, Velthorst E. Lifespan evolution of neurocognitive impairment in schizophrenia - A narrative review. Schizophr Res Cogn. 2022; 28: 100237.

47. Bora E, Murray RM. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull. 2014; 40: 744–755.

5. You need to add a Conclusions section.

Thank you for the suggestion. The section was added as suggested (p. 16, line 361-368).

6. It is necessary to transfer the information from the Discussion section to the special section "Restrictions of the study".

The paragraph was removed from the Discussion section to the newly-created "Limitations" section (p. 15, line 352-359).

Data availability

The S1 Data file is now included in the revised submission to provide individual curvature values. This item is now cited in p. 8, line 185. We are not certain whether this type of data is appropriate for the publication in this journal. If it's appropriate, we would like to include it as Supporting Information. If not, we do not claim its publication. It can be used only for reviewing purposes.

Attachments
Attachment
Submitted filename: rebuttal230511.docx
Decision Letter - Thiago P. Fernandes, Editor

Structural aging of human neurons is opposite of the changes in schizophrenia

PONE-D-23-07288R1

Dear Dr. Mizutani,

Hi - I’d just ask the authors to (1) change “opposite” to another synonym and (2) refine eligibility criteria, like the use of meds, BDNF and other factors that weren’t assessed etc.

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Thiago P. Fernandes, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for your thoughtful and careful edits.

Wishing you success with the study.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Accept. The authors have addressed the points this referee raised. They also seem to have covered the points raised by the other referee.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Stuart R. Stock

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Thiago P. Fernandes, Editor

PONE-D-23-07288R1

Structural aging of human neurons is opposite of the changes in schizophrenia

Dear Dr. Mizutani:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Thiago P. Fernandes

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .